Nov/Dec 2015: Volume 16 Number 11/12
1 December 2015. Related: Editorial.
2015
15th European AIDS Conference (EACS), 21-24 October 2015, Barcelona
1 December 2015. Related: Conference reports.
Remarkable results with dolutegravir monotherapy
1 December 2015. Related: Conference reports, Antiretrovirals, Vaccines and microbicides.
First-line ART with dolutegravir plus 3TC: 24-week early results
1 December 2015. Related: Conference reports, Antiretrovirals, Treatment strategies.
New European HIV guidelines (October 2015): universal ART, first-line integrase and PrEP
1 December 2015. Related: Conference reports, Guidelines.
Impact of early ART on lung function: results on ART and COPD from START substudy
1 December 2015. Related: Conference reports, Coinfections and complications.
No difference in neuropsychological test results between early and delayed ART in START substudy
1 December 2015. Related: Conference reports, Side effects, Coinfections and complications.
Immediate ART in START linked to greater bone loss over three years
1 December 2015. Related: Conference reports, Side effects.
Price of MDR TB drugs could be greatly reduced with competitive generic manufacture
1 December 2015. Related: Conference reports, Treatment access, TB coinfection.
Potential for generic prices for 12 weeks sofosbuvir treatment to drop below US $300 and daclatasvir to US $23
1 December 2015. Related: Conference reports, Treatment access, Hepatitis coinfection.
Achieving viral suppression with HIV multi-drug resistance: peg-interferon and valaciclovir as part of rescue therapy
1 December 2015. Related: Conference reports, Antiretrovirals, Treatment strategies, Drug resistance.
French cohort of HIV transgender women highlights issues relating to HIV management
1 December 2015. Related: Conference reports.
7th International Workshop on HIV Paediatrics, 17-18 July, Vancouver, Canada
1 December 2015. Related: Conference reports.
Substituting lopinavir/ritonavir with efavirenz in children on stable ART
1 December 2015. Related: Conference reports, Antiretrovirals, Paediatric care.
The effects of systemic efavirenz exposure, sex and age on risk of viral non-suppression
1 December 2015. Related: Conference reports, Paediatric care, PK and drug interactions.
Pharmacokinetics of lopinavir/ritonavir super-boosting in infants and young children co-infected with HIV and TB
1 December 2015. Related: Conference reports, Paediatric care, PK and drug interactions, TB coinfection.
CHAI’s ARV market report predicts that new drugs and formulations will drive the next major drop in treatment costs
1 December 2015. Related: Treatment access.
New trade agreements threaten treatment access in Asia
1 December 2015. Related: Treatment access.
Tenofovir alafenamide (TAF) approved – but only as part of a fixed dose combination
1 December 2015. Related: Antiretrovirals.
European HIV guidelines updated (October 2015)
1 December 2015. Related: Guidelines.
New UK guidelines on use of vaccines in HIV positive adults (2015)
1 December 2015. Related: Guidelines.
IAS-USA update resistance guidelines and mutation tables (2015)
1 December 2015. Related: Guidelines.
HIV rates still increasing in gay men: 2015 report
1 December 2015. Related: HIV prevention and transmission, Other news.
PrEP to be available free in France from January 2016
1 December 2015. Related: HIV prevention and transmission.
PrEP efficacy for transgender women: new analysis from iPrEX study
1 December 2015. Related: HIV prevention and transmission.
PrEP in a clinical setting: no infections reported in San Francisco cohort
1 December 2015. Related: HIV prevention and transmission.
New free self-sampling HIV home testing service launched in England
1 December 2015. Related: HIV prevention and transmission.
NICE decision on ledipasvir/sofosbuvir for chronic HCV
1 December 2015. Related: Hepatitis coinfection.
Sofosbuvir/velpatasvir submitted to US FDA for HCV genotype 1-6
1 December 2015. Related: Hepatitis coinfection.
US indication for ledipasvir/sofosbuvir expanded
1 December 2015. Related: Hepatitis coinfection.
Why START would make an excellent long-term cohort
1 December 2015. Related: Research studies.
Why dolutegravir might get us closer to ending AIDS: next step, further research
1 December 2015. Related: Research studies.
November/December 2015: Volume 16 Number 11/12
1 December 2015. Related: PDFs.
September/October 2015: Volume 16 Number 9/10
21 October 2015. Related: PDFs.
Sept/Oct 2015: Volume 16 Number 9/10
1 October 2015. Related: Editorial.
Two new i-Base resources: Introduction to ART booklet and a Pocket ART leaflet
1 October 2015. Related: Supplements.
55th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 17-21 September 2015, San Diego
1 October 2015. Related: Conference reports.
No transmission of integrase-resistant HIV seen in California cohort
1 October 2015. Related: Conference reports, Antiretrovirals, HIV prevention and transmission, Drug resistance.
Doubled hypogonadism rate in middle-aged men with HIV: fat is a factor
1 October 2015. Related: Conference reports, Antiretrovirals, Side effects.
Protection against flu but not HBV in vaccinated perinatally HIV-infected children
1 October 2015. Related: Conference reports, Paediatric care, Hepatitis coinfection.
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), 19-22 July 2015, Vancouver, Canada
1 October 2015. Related: Conference reports.
The PrEP experience: IAS 2015 and beyond
1 October 2015. Related: Conference reports, HIV prevention and transmission.
Raltegravir for neonates will require a complicated dosing regimen
1 October 2015. Related: Conference reports, Pregnancy, Paediatric care.
News and notes on HIV cure research from IAS 2015
1 October 2015. Related: Conference reports, Cure-related research.
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, 26-28 May 2015, Washington DC
1 October 2015. Related: Conference reports.
Reducing efavirenz dose is unlikely to overcome interaction with levonorgestrel
1 October 2015. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy, PK and drug interactions.
Doravirine and cabotegravir do not affect the pharmacokinetics of oral contraceptives
1 October 2015. Related: Conference reports, Antiretrovirals, Women's health, PK and drug interactions.
Pharmacokinetics of four antiretrovirals in pregnancy: data from the PANNA network
1 October 2015. Related: Conference reports, Pregnancy, PK and drug interactions.
Dolutegravir placental transfer moderate in ex vivo model
1 October 2015. Related: Conference reports, Antiretrovirals, Pregnancy, PK and drug interactions.
Paediatric dosing of DRV/r
1 October 2015. Related: Conference reports, Paediatric care, PK and drug interactions.
Why the 5000% price hike for pyrimethamine in the US is relevant in the UK
1 October 2015. Related: Treatment access.
Proposed TTIP trade agreement in Europe: Report shows European Commission’s access to medicines commitments are ‘empty gestures’
1 October 2015. Related: Treatment access.
FDA approve additional weight band dosing for children using atazanavir powder
1 October 2015. Related: Antiretrovirals, Paediatric care.
UK BHIVA treatment guidelines for HIV positive adults (2015)
1 October 2015. Related: Guidelines.
WHO guidelines for when to start ART and use of PrEP (September 2015)
1 October 2015. Related: Guidelines.
Neurocognitive disorder, persistent inverted CD4:CD8 ratios and immune activation in the CNS
1 October 2015. Related: Side effects.
i-Base Q&A resources on PrEP: increased use of off-label PrEP in the UK shows need for NHS support and risk to PEP services
1 October 2015. Related: HIV prevention and transmission.
Two new UK community PrEP websites
1 October 2015. Related: HIV prevention and transmission, On the web.
First UK NHS PrEP support service launched at 56 Dean Street, Soho
1 October 2015. Related: HIV prevention and transmission.
UK PROUD study published as open access article in The Lancet: PrEP dramatically reduces risk of HIV
1 October 2015. Related: HIV prevention and transmission.
Gilead to provide free hepatitis drugs to treat all people liviing with hepatitis C in Iceland
1 October 2015. Related: Hepatitis coinfection.
Australian doctors advice for buying generic sofosbuvir for HepC
1 October 2015. Related: Treatment access, Hepatitis coinfection.
Combining PKC agonists and bromodomain inhibitors to reverse HIV latency
1 October 2015. Related: Cure-related research, Basic science and immunology.
Estimating how frequently latent HIV reactivates
1 October 2015. Related: Cure-related research, Basic science and immunology.
Professor Clive Loveday awarded a Royal Order of Chivalry
1 October 2015. Related: Other news.